Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Michael Cullen
FOU | Founder | 78 | 21/09/11 |
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16/07/20 |
Susan Horvath
DFI | Director of Finance/CFO | 65 | 17/04/18 |
Tammy Groene
COO | Chief Operating Officer | - | 01/04/12 |
Chief Tech/Sci/R&D Officer | - | 01/06/22 | |
Rachel Bragg
PRN | Corporate Officer/Principal | - | 01/06/21 |
- | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16/07/20 |
Director/Board Member | 63 | 30/09/15 | |
Michael Cullen
FOU | Founder | 78 | 21/09/11 |
Jeffrey Jacob
BRD | Director/Board Member | 62 | 15/06/22 |
Arthur Fratamico
BRD | Director/Board Member | 58 | 16/12/19 |
Dan Donovan
BRD | Director/Board Member | 59 | 15/06/22 |
Donald Schemel
BRD | Director/Board Member | 68 | 04/09/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 854 931 | 4 854 791 ( 100,00 %) | 70 ( 0,001442 %) | 100,00 % |
Información de la empresa
Panbela Therapeutics, Inc.
712 Vista Boulevard Suite 305
55387, Waconia
+952 479 1196
http://www.panbela.comVaria. 1 de ene. | Capi. | |
---|---|---|
+14,46 % | 3.161000 M | |
+11,18 % | 87,62 mil M | |
+6,57 % | 79,59 mil M | |
-12,92 % | 54,14 mil M | |
+23,79 % | 48,15 mil M | |
+32,74 % | 47,69 mil M | |
-24,97 % | 46,81 mil M | |
+81,19 % | 42 mil M | |
-6,03 % | 25,77 mil M |
- Bolsa de valores
- Acciones
- Acción
- Empresa Sun Biopharma Inc